Abstract
Patients with anorexia nervosa (AN) often experience low bone mineral density (BMD) and increased fracture risk, with low body weight and decreased gonadal function being the strongest predictors of the observed bone mineral deficit and fractures. Other metabolic disturbances have also been linked to bone loss in this group of patients, including growth hormone resistance, low insulin-like growth factor-1 (IGF-1) concentrations, low leptin concentrations, and hypercortisolemia. However, these correlations lack definitive evidence of causality. Weight restoration and resumption of menstrual function have the strongest impact on increasing BMD. Other potential treatment options include bisphosphonates and teriparatide, supported by data from small clinical trials, but these agents are not approved for the treatment of low BMD in adolescents or premenopausal women with AN.
Similar content being viewed by others
References
Grinspoon S (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133:790. https://doi.org/10.7326/0003-4819-133-10-200011210-00011
Frølich J, Winkler LA, Abrahamsen B, Bilenberg N, Hermann AP, Støving RK (2020) Assessment of fracture risk in women with eating disorders: the utility of dual-energy x-ray absorptiometry (DXA)—clinical cohort study. Int J Eat Disord 53:595–605. https://doi.org/10.1002/eat.23245
Hübel C, Yilmaz Z, Schaumberg KE, Breithaupt L, Hunjan A, Horne E, García-González J, O’Reilly PF, Bulik CM, Breen G (2019) Body composition in anorexia nervosa: meta-analysis and meta-regression of cross-sectional and longitudinal studies. Int J Eat Disord 52:1205–1223. https://doi.org/10.1002/eat.23158
Nagata JM, Golden NH, Peebles R, Long J, Leonard MB, Chang AO, Carlson JL (2017) Assessment of sex differences in bone deficits among adolescents with anorexia nervosa. Int J Eat Disord 50:352–358. https://doi.org/10.1002/eat.22626
Misra M, Katzman DK, Cord J, Manning SJ, Mendes N, Herzog DB, Miller KK, Klibanski A (2008) Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 93:3029–3036. https://doi.org/10.1210/jc.2008-0170
Mehler PS, Sabel AL, Watson T, Andersen AE (2008) High risk of osteoporosis in male patients with eating disorders. Int J Eat Disord 41:666–672. https://doi.org/10.1002/eat.20554
Schorr M, Drabkin A, Rothman MS, Meenaghan E, Lashen GT, Mascolo M, Watters A, Holmes TM, Santoso K, Yu EW, Misra M, Eddy KT, Klibanski A, Mehler P, Miller KK (2019) Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder. Clin Endocrinol (Oxf) 90:789–797. https://doi.org/10.1111/cen.13960
Workman C, Blalock DV, Mehler PS (2020) Bone density status in a large population of patients with anorexia nervosa. Bone 131:115161. https://doi.org/10.1016/j.bone.2019.115161
Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A (1996) Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864–3870. https://doi.org/10.1210/jcem.81.11.8923830
Hotta M, Shibasaki T, Sato K, Demura H (1998) The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. Eur J Endocrinol 139:276–283. https://doi.org/10.1530/eje.0.1390276
Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A (1999) The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 84:4489–4496. https://doi.org/10.1210/jc.84.12.4489
Idolazzi L, El Ghoch M, Dalle Grave R, Bazzani PV, Calugi S, Fassio S, Caimmi C, Viapiana O, Bertoldo F, Braga V, Rossini M, Gatti D (2018) Bone metabolism in patients with anorexia nervosa and amenorrhoea. Eat Weight Disord - Stud Anorex Bulim Obes 23:255–261. https://doi.org/10.1007/s40519-016-0337-x
Lucas AR, Melton LJ, Crowson CS, O’Fallon WM (1999) Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 74:972–977. https://doi.org/10.4065/74.10.972
Schorr M, Thomas JJ, Eddy KT, Dichtel LE, Lawson EA, Meenaghan E, Lederfine Paskal M, Fazeli PK, Faje AT, Misra M, Klibanski A, Miller KK (2017) Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord 50:343–351. https://doi.org/10.1002/eat.22603
Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders-a nationwide register study. Int J Eat Disord 32:301–308. https://doi.org/10.1002/eat.10101
Faje AT, Fazeli PK, Miller KK, Katzman DK, Ebrahimi S, Lee H, Mendes N, Snelgrove D, Meenaghan E, Misra M, Klibanski A (2014) Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47:458–466. https://doi.org/10.1002/eat.22248
Frølich J, Winkler LA, Abrahamsen B, Bilenberg N, Hermann AP, Støving RK (2020) Fractures in women with eating disorders—incidence, predictive factors, and the impact of disease remission: cohort study with background population controls. Int J Eat Disord 53:1080–1087. https://doi.org/10.1002/eat.23223
Nagata JM, Golden NH, Leonard MB, Copelovitch L, Denburg MR (2017) Assessment of sex differences in fracture risk among patients with anorexia nervosa: a population-based cohort study using the health improvement network. J Bone Miner Res 32:1082–1089. https://doi.org/10.1002/jbmr.3068
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259. https://doi.org/10.1136/bmj.312.7041.1254
Dang T, Faje AT, Meenaghan E, Bredella M, Klibanski A, Fazeli PK (2020) SUN-350 bone marrow adipose tissue is associated with fracture prevalence in anorexia nervosa. J Endocr Soc. https://doi.org/10.1210/jendso/bvaa046.1060
Faje AT, Karim L, Taylor A, Lee H, Miller KK, Mendes N, Meenaghan E, Goldstein MA, Bouxsein ML, Misra M, Klibanski A (2013) Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab 98:1923–1929. https://doi.org/10.1210/jc.2012-4153
Singhal V, Tulsiani S, Campoverde KJ, Mitchell DM, Slattery M, Schorr M, Miller KK, Bredella MA, Misra M, Klibanski A (2018) Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. Bone 106:61–68. https://doi.org/10.1016/j.bone.2017.07.009
Frølich J, Hansen S, Winkler LA-D, Andresen AK, Hermann AP, Støving RK (2017) The role of body weight on bone in anorexia nervosa: a HR-pQCT study. Calcif Tissue Int 101:24–33. https://doi.org/10.1007/s00223-017-0254-7
Devlin MJ, Rosen CJ (2015) The bone–fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol 3:141–147. https://doi.org/10.1016/S2213-8587(14)70007-5
Karampinos DC, Ruschke S, Gordijenko O, Grande Garcia E, Kooijman H, Burgkart R, Rummeny EJ, Bauer JS, Baum T (2015) Association of MRS-based vertebral bone marrow fat fraction with bone strength in a human in vitro model. J Osteoporos 2015:1–8. https://doi.org/10.1155/2015/152349
Badr S, Legroux-Gérot I, Vignau J, Chauveau C, Ruschke S, Karampinos DC, Budzik J-F, Cortet B, Cotten A (2019) Comparison of regional bone marrow adiposity characteristics at the hip of underweight and weight-recovered women with anorexia nervosa using magnetic resonance spectroscopy. Bone 127:135–145. https://doi.org/10.1016/j.bone.2019.05.033
Dimitri P (2019) The impact of childhood obesity on skeletal health and development. J Obes Metab Syndr 28:4–17. https://doi.org/10.7570/jomes.2019.28.1.4
Ecklund K, Vajapeyam S, Mulkern RV, Feldman HA, O’Donnell JM, DiVasta AD, Gordon CM (2017) Bone marrow fat content in 70 adolescent girls with anorexia nervosa: magnetic resonance imaging and magnetic resonance spectroscopy assessment. Pediatr Radiol 47:952–962. https://doi.org/10.1007/s00247-017-3856-3
Newton AL, Hanks LJ, Davis M, Casazza K (2013) The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls. Bonekey Rep 2:315. https://doi.org/10.1038/bonekey.2013.49
American Psychiatric Association (2013) DSM-5 diagnostic classification. Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, D.C
Misra M, Katzman DK, Clarke H, Snelgrove D, Brigham K, Miller KK, Klibanski A (2013) Hip structural analysis in adolescent boys with anorexia nervosa and controls. J Clin Endocrinol Metab 98:2952–2958. https://doi.org/10.1210/jc.2013-1457
Legroux-Gérot I, Vignau J, D’Herbomez M, Collier F, Marchandise X, Duquesnoy B, Cortet B (2007) Evaluation of bone loss and its mechanisms in anorexia nervosa. Calcif Tissue Int 81:174–182. https://doi.org/10.1007/s00223-007-9038-9
Legroux-Gérot I, Vignau J, D’Herbomez M, Flipo R-M, Cortet B (2012) Predictive factors of change in BMD at 1 and 2 years in women with anorexia nervosa: a study of 146 cases. Osteoporos Int 23:2855–2861. https://doi.org/10.1007/s00198-012-1919-8
Halvorsen I, Platou D, Høiseth A (2012) Bone mass eight years after treatment for adolescent-onset anorexia nervosa. Eur Eat Disord Rev 20:386–392. https://doi.org/10.1002/erv.2179
Franzoni E, Ciccarese F, Di Pietro E, Facchini G, Moscano F, Iero L, Monaldi A, Battista G, Bazzocchi A (2014) Follow-up of bone mineral density and body composition in adolescents with restrictive anorexia nervosa: role of dual-energy X-ray absorptiometry. Eur J Clin Nutr 68:247–252. https://doi.org/10.1038/ejcn.2013.254
Misra M, Aggarwal A, Miller KK, Almazan C, Worley M, Soyka LA, Herzog DB, Klibanski A (2004) Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114:1574–1583. https://doi.org/10.1542/peds.2004-0540
Miller KK, Lee EE, Lawson EA, Misra M, Minihan J, Grinspoon SK, Gleysteen S, Mickley D, Herzog D, Klibanski A (2006) Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91:2931–2937. https://doi.org/10.1210/jc.2005-2818
Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, Loewenthal R, Yissachar E, Hemi R, Kanety H (2007) Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 92:1843–1847. https://doi.org/10.1210/jc.2006-1683
Lawson EA, Miller KK, Bredella MA, Phan C, Misra M, Meenaghan E, Rosenblum L, Donoho D, Gupta R, Klibanski A (2010) Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 46:458–463. https://doi.org/10.1016/j.bone.2009.09.005
Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987–997. https://doi.org/10.1056/NEJMoa040388
Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, Arampatzi KM, Gao C, Koniaris A, Mantzoros CS (2011) Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 60:1211–1221. https://doi.org/10.1016/j.metabol.2011.05.016
Misra M, Klibanski A (2014) Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol 2:581–592. https://doi.org/10.1016/S2213-8587(13)70180-3
Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23:576–581. https://doi.org/10.1016/j.tem.2012.03.008
Biller BMK, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A (1989) Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68:548–554. https://doi.org/10.1210/jcem-68-3-548
Golden NH (1997) Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 151:16–21. https://doi.org/10.1001/archpedi.1997.02170380020003
Kandemir N, Becker K, Slattery M, Tulsiani S, Singhal V, Thomas JJ, Coniglio K, Lee H, Miller KK, Eddy KT, Klibanski A, Misra M (2017) Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord 50:359–369. https://doi.org/10.1002/eat.22681
Do Carmo I, Mascarenhas M, Macedo A, Silva A, Santos I, Bouça D, Myatt J, Sampaio D (2007) A study of bone density change in patients with anorexia nervosa. Eur Eat Disord Rev 15:457–462. https://doi.org/10.1002/erv.812
Solmi M, Veronese N, Correll CU, Favaro A, Santonastaso P, Caregaro L, Vancampfort D, Luchini C, De Hert M, Stubbs B (2016) Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 133:341–351. https://doi.org/10.1111/acps.12556
Riggs BL, Khosla S, Melton LJ (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302. https://doi.org/10.1210/edrv.23.3.0465
Tomova A, Kumanov P (1999) Sex differences and similarities of hormonal alterations in patients with anorexia nervosa. Andrologia 31:143–147. https://doi.org/10.1046/j.1439-0272.1999.00262.x
Howgate DJ, Graham SM, Leonidou A, Korres N, Tsiridis E, Tsapakis E (2013) Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities. Osteoporos Int 24:407–421. https://doi.org/10.1007/s00198-012-2095-6
Gordon CM, Goodman E, Emans SJ, Grace E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS (2002) Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 141:64–70. https://doi.org/10.1067/mpd.2002.125003
Ostrowska Z, Ziora K, Oświęcimska J, Świętochowska E, Wołkowska-Pokrywa K (2012) Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. Postepy Hig Med Dosw 66:655–662. https://doi.org/10.5604/17322693.1009971
Misra M, Miller KK, Bjornson J, Hackman A, Aggarwal A, Chung J, Ott M, Herzog DB, Johnson ML, Klibanski A (2003) Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88:5615–5623. https://doi.org/10.1210/jc.2003-030532
Argente J (1997) Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Clin Endocrinol Metab 82:2084–2092. https://doi.org/10.1210/jc.82.7.2084
Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883–2891. https://doi.org/10.1210/jcem.87.6.8574
Guerra-Menéndez L, Sádaba MC, Puche JE, Lavandera JL, de Castro LF, de Gortázar AR, Castilla-Cortázar I (2013) IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. J Transl Med 11:271. https://doi.org/10.1186/1479-5876-11-271
Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB (1992) The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 75:762–767. https://doi.org/10.1210/jcem.75.3.1381372
Trombetti A, Richert L, Herrmann FR, Chevalley T, Graf J-D, Rizzoli R (2013) Selective determinants of low bone mineral mass in adult women with anorexia nervosa. Int J Endocrinol 2013:1–9. https://doi.org/10.1155/2013/897193
Chyun YS, Kream BE, Raisz LG (1984) Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology 114:477–480. https://doi.org/10.1210/endo-114-2-477
Canalis E, Delany AM (2002) Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 966:73–81. https://doi.org/10.1111/j.1749-6632.2002.tb04204.x
Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A (1999) Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea1. J Clin Endocrinol Metab 84:2049–2055. https://doi.org/10.1210/jcem.84.6.5792
Colaianni G, Tamma R, Di Benedetto A, Yuen T, Sun L, Zaidi M, Zallone A (2014) The oxytocin-bone axis. J Neuroendocrinol 26:53–57. https://doi.org/10.1111/jne.12120
Kaye WH (1996) Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 62:65–74. https://doi.org/10.1016/0165-1781(96)02985-X
Maguire S, O’Dell A, Touyz L, Russell J (2013) Oxytocin and anorexia nervosa: a review of the emerging literature. Eur Eat Disord Rev 21:475–478. https://doi.org/10.1002/erv.2252
Schorr M, Marengi DA, Pulumo RL, Yu E, Eddy KT, Klibanski A, Miller KK, Lawson EA (2017) Oxytocin and its relationship to body composition, bone mineral density, and hip geometry across the weight spectrum. J Clin Endocrinol Metab 102:2814–2824. https://doi.org/10.1210/jc.2016-3963
Kiriike N, Iketani T, Nakanishi S, Nagata T, Inoue K, Okuno M, Ochi H, Kawakita Y (1992) Reduced bone density and major hormones regulating calcium metabolism in anorexia nervosa. Acta Psychiatr Scand 86:358–363. https://doi.org/10.1111/j.1600-0447.1992.tb03280.x
Lenherr-Taube N, Trajcevski K, Sochett E, Katzman DK (2020) Low PTH levels in adolescents with anorexia nervosa. Front Pediatr 8:1–7. https://doi.org/10.3389/fped.2020.00099
Carmichael KA, Carmichael DH (1995) Bone metabolism and osteopenia in eating disorders. Medicine (Baltimore) 74:254–267. https://doi.org/10.1097/00005792-199509000-00003
Legroux-Gérot I, Vignau J, Viltart O, Hardouin P, Chauveau C, Cortet B (2019) Adipokines and bone status in a cohort of anorexic patients. Jt Bone Spine 86:95–101. https://doi.org/10.1016/j.jbspin.2018.03.014
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935. https://doi.org/10.1210/jcem.86.5.7463
Misra M, Miller KK, Cord J, Prabhakaran R, Herzog DB, Goldstein M, Katzman DK, Klibanski A (2007) Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 92:2046–2052. https://doi.org/10.1210/jc.2006-2855
Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De Giacomo P, Giorgino R, De Pergola G (2003) Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88:1748–1752. https://doi.org/10.1210/jc.2002-021215
Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M (2005) Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90:1366–1370. https://doi.org/10.1210/jc.2004-1364
Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H (2004) Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 89:1833–1837. https://doi.org/10.1210/jc.2003-031260
Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA (2010) Adiponectin and bone mass density: the InCHIANTI study. Bone 47:1001–1005. https://doi.org/10.1016/j.bone.2010.08.010
Leitch VD, Brassill MJ, Rahman S, Butterfield NC, Ma P, Logan JG, Boyde A, Evans H, Croucher PI, Batterham RL, Williams GR, Bassett JHD (2019) PYY is a negative regulator of bone mass and strength. Bone 127:427–435. https://doi.org/10.1016/j.bone.2019.07.011
Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK (2008) Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 43:135–139. https://doi.org/10.1016/j.bone.2008.03.007
Wong IPL, Driessler F, Khor EC, Shi Y-C, Hörmer B, Nguyen AD, Enriquez RF, Eisman JA, Sainsbury A, Herzog H, Baldock PA (2012) Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS ONE 7:e40038. https://doi.org/10.1371/journal.pone.0040038
Achamrah N, Coëffier M, Déchelotte P (2016) Physical activity in patients with anorexia nervosa. Nutr Rev 74:301–311. https://doi.org/10.1093/nutrit/nuw001
Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, Harbour RT, Caldwell LM, Creed G (2011) Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000333.pub2
Waugh EJ, Woodside DB, Beaton DE, Coté P, Hawker GA (2011) Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 43:755–763. https://doi.org/10.1249/MSS.0b013e3181ff3961
Mika C, Holtkamp K, Heer M, Günther RW, Herpertz-Dahlmann B (2007) A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm 114:1611–1618. https://doi.org/10.1007/s00702-007-0787-4
Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, Lockhart P, Cord J, Herzog DB, Katzman DK, Klibanski A (2008) Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 93:1231–1237. https://doi.org/10.1210/jc.2007-1434
Schulze UM, Schuler S, Schlamp D, Schneider P, Mehler-Wex C (2010) Bone mineral density in partially recovered early onset anorexic patients—a follow-up investigation. Child Adolesc Psychiatry Ment Health 4:20. https://doi.org/10.1186/1753-2000-4-20
Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R (1991) Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 72:602–606. https://doi.org/10.1210/jcem-72-3-602
Kooh SW, Noriega E, Leslie K, Müller C, Harrison JE (1996) Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone 19:181–188. https://doi.org/10.1016/8756-3282(96)00162-7
Caillot-Augusseau A, Lafage-Proust M-H, Margaillan P, Vergely N, Faure S, Paillet S, Lang F, Alexandre C, Estour B (2000) Weight gain reverses bone turnover and restores circadian variation of bone resorption in anorexic patients. Clin Endocrinol (Oxf) 52:113–121. https://doi.org/10.1046/j.1365-2265.2000.00879.x
Jagielska G, Wolańczyc T, Komender J, Tomaszewicz-Libudzic C, Przedlaki J, Ostrowski K (2001) Bone mineral content and bone mineral density in adolescent girls with anorexia nervosa—a longitudinal study. Acta Psychiatr Scand 104:131–137. https://doi.org/10.1034/j.1600-0447.2001.00286.x
Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, Klibanski A (2002) Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177–4185. https://doi.org/10.1210/jc.2001-011889
Castro J, Toro J, Lázaro L, Pons F, Halperin I (2002) Bone mineral density in male adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 41:613–618. https://doi.org/10.1097/00004583-200205000-00019
Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR (2005) Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179–3185. https://doi.org/10.1210/jc.2004-1659
Stone M, Briody J, Kohn MR, Clarke S, Madden S, Cowell CT (2006) Bone changes in adolescent girls with anorexia nervosa. J Adolesc Health 39:835–841. https://doi.org/10.1016/j.jadohealth.2006.09.011
Compston JE, McConachie C, Stott C, Hannon RA, Kaptoge S, Debiram I, Love S, Jaffa A (2006) Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 17:77–84. https://doi.org/10.1007/s00198-005-1904-6
Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R, Patel S (2000) Bone density of women who have recovered from anorexia nervosa. Int J Eat Disord 28:107–112. https://doi.org/10.1002/(SICI)1098-108X(200007)28:1%3c107::AID-EAT13%3e3.0.CO;2-M
Mueller SM, Immoos M, Anliker E, Drobnjak S, Boutellier U, Toigo M (2015) Reduced bone strength and muscle force in women 27 years after anorexia nervosa. J Clin Endocrinol Metab 100:2927–2933. https://doi.org/10.1210/jc.2015-1011
Chiurazzi C, Cioffi I, De Caprio C, De Filippo E, Marra M, Sammarco R, Di Guglielmo ML, Contaldo F, Pasanisi F (2017) Adequacy of nutrient intake in women with restrictive anorexia nervosa. Nutrition 38:80–84. https://doi.org/10.1016/j.nut.2017.02.004
Mehler PS, Blalock DV, Walden K, Kaur S, McBride J, Walsh K, Watts J (2018) Medical findings in 1,026 consecutive adult inpatient-residential eating disordered patients. Int J Eat Disord 51:305–313. https://doi.org/10.1002/eat.22830
Carlsson M, Brudin L, Wanby P (2018) Directly measured free 25-hydroxy vitamin D levels show no evidence of vitamin D deficiency in young Swedish women with anorexia nervosa. Eat Weight Disord - Stud Anorex Bulim Obes 23:247–254. https://doi.org/10.1007/s40519-017-0392-y
Haagensen AL, Feldman HA, Ringelheim J, Gordon CM (2008) Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int 19:289–294. https://doi.org/10.1007/s00198-007-0476-z
Hotta M (2015) High prevalence of vitamin D insufficiency and deficiency among patients with anorexia nervosa in Japan. Osteoporos Int 26:1233–1233. https://doi.org/10.1007/s00198-014-2957-1
Modan-Moses D, Levy-Shraga Y, Pinhas-Hamiel O, Kochavi B, Enoch-Levy A, Vered I, Stein D (2015) High prevalence of vitamin D deficiency and insufficiency in adolescent inpatients diagnosed with eating disorders. Int J Eat Disord 48:607–614. https://doi.org/10.1002/eat.22347
Veronese N, Solmi M, Rizza W, Manzato E, Sergi G, Santonastaso P, Caregaro L, Favaro A, Correll CU (2015) Vitamin D status in anorexia nervosa: a meta-analysis. Int J Eat Disord 48:803–813. https://doi.org/10.1002/eat.22370
Misra M, Tsai P, Anderson EJ, Hubbard JL, Gallagher K, Soyka LA, Miller KK, Herzog DB, Klibanski A (2006) Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 84:698–706. https://doi.org/10.1093/ajcn/84.4.698
Giollo A, Idolazzi L, Caimmi C, Fassio A, Bertoldo F, Dalle Grave R, El Ghoch M, Calugi S, Bazzani PV, Viapiana O, Rossini M, Gatti D (2017) Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa. Int J Eat Disord 50:1041–1049. https://doi.org/10.1002/eat.22731
Svedlund A, Pettersson C, Tubic B, Magnusson P, Swolin-Eide D (2017) Vitamin D status in young Swedish women with anorexia nervosa during intensive weight gain therapy. Eur J Nutr 56:2061–2067. https://doi.org/10.1007/s00394-016-1244-7
Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R (2009) Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7:1467–1474. https://doi.org/10.1002/jbmr.5650071215
Karlsson MK, Weigall SJ, Duan Y, Seeman E (2000) Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab 85:3177–3182. https://doi.org/10.1210/jcem.85.9.6796
Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC (1995) The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898–904. https://doi.org/10.1210/jcem.80.3.7883849
Resulaj M, Polineni S, Meenaghan E, Eddy K, Lee H, Fazeli PK (2020) Transdermal estrogen in women with anorexia nervosa: an exploratory pilot study. JBMR Plus 4:e10251. https://doi.org/10.1002/jbm4.10251
Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR (2002) The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 15:135–143. https://doi.org/10.1016/S1083-3188(02)00145-6
Muñoz M, Morande G, Garcia-Centenera J, Hervas F, Pozo J, Argente J (2002) The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 146:45–50. https://doi.org/10.1530/eje.0.1460045
Strokosch GR, Friedman AJ, Wu S-C, Kamin M (2006) Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 39:819–827. https://doi.org/10.1016/j.jadohealth.2006.09.010
Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld DA, Herzog DB, Klibanski A (2011) Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 26:2430–2438. https://doi.org/10.1002/jbmr.447
Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomark Prev 10:377–384
Miller KK, Grieco KA, Klibanski A (2005) Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 90:1428–1433. https://doi.org/10.1210/jc.2004-1181
Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D, Herzog D, Klibanski A (2011) Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, Placebo-Controlled Study. J Clin Endocrinol Metab 96:2081–2088. https://doi.org/10.1210/jc.2011-0380
Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y (2012) Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Res 200:544–549. https://doi.org/10.1016/j.psychres.2012.07.012
Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS (2002) Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87:4935–4941. https://doi.org/10.1210/jc.2002-020545
DiVasta AD, Feldman HA, Giancaterino C, Rosen CJ, LeBoff MS, Gordon CM (2012) The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 61:1010–1020. https://doi.org/10.1016/j.metabol.2011.11.016
DiVasta AD, Feldman HA, Beck TJ, LeBoff MS, Gordon CM (2014) Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res 29:151–157. https://doi.org/10.1002/jbmr.2005
DiVasta AD, Feldman HA, O’Donnell JM, Long J, Leonard MB, Gordon CM (2019) Impact of adrenal hormone supplementation on bone geometry in growing teens with anorexia nervosa. J Adolesc Health 65:462–468. https://doi.org/10.1016/j.jadohealth.2019.04.003
Zimolo Z, Wesolowski G, Rodan GA (1995) Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin. J Clin Invest 96:2277–2283. https://doi.org/10.1172/JCI118283
Hughes DE, MacDonald BR, Russell RGG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930–1935. https://doi.org/10.1172/JCI114100
Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman DG, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478–1487. https://doi.org/10.1002/jbmr.5650101008
Miller KK, Grieco KA, Mulder J, Grinspoon S, Mickley D, Yehezkel R, Herzog DB, Klibanski A (2004) Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89:3903–3906. https://doi.org/10.1210/jc.2003-031885
Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G, Scully S, Elliott R, Grisanti M, Morony S, Hong LT et al (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. J Bone Miner Res 24:182–195. https://doi.org/10.1359/jbmr.081112
Jamieson A, Pelosi AJ (2016) Use of denosumab in a patient with chronic anorexia nervosa and osteoporosis. Am J Med 129:e47. https://doi.org/10.1016/j.amjmed.2015.07.040
Isobe F, Nakamura Y, Suzuki T, Kato H (2018) Effects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literature. Mod Rheumatol Case Rep 2:104–106. https://doi.org/10.1080/24725625.2017.1370784
Kilbane MT, Crowley RK, Twomey PJ, Maher C, McKenna MJ (2020) Anorexia nervosa with markedly high bone turnover and hyperphosphatemia during refeeding rectified by denosumab. Osteoporos Int 31:1395–1398. https://doi.org/10.1007/s00198-020-05307-1
Anand P, Mehler PS (2019) Osteoporosis recovery in severe anorexia nervosa: a case report. J Eat Disord 7:38. https://doi.org/10.1186/s40337-019-0269-8
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439–446. https://doi.org/10.1172/JCI6610
Pfeilschifter J, Laukhuf F, Müller-Beckmann B, Blum WF, Pfister T, Ziegler R (1995) Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767–774. https://doi.org/10.1172/JCI118121
Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A (1995) Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16:357–365. https://doi.org/10.1016/8756-3282(94)00051-4
Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, Finkelstein JS, Bouxsein ML, Klibanski A (2014) Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 99:1322–1329. https://doi.org/10.1210/jc.2013-4105
Milos G, Moergeli H, Sob C, Wisler D, Wasila M, Uebelhart D, Frey D (2021) Positive effect of teriparatide on areal bone mineral density in young women with anorexia nervosa: a pilot study. Calcif Tissue Int. https://doi.org/10.1007/s00223-020-00791-3
Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559. https://doi.org/10.1210/er.2007-0036
Misra M, McGrane J, Miller KK, Goldstein MA, Ebrahimi S, Weigel T, Klibanski A (2009) Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 45:493–498. https://doi.org/10.1016/j.bone.2009.06.002
Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, Herzog DB, Misra M, Klibanski A (2010) Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 95:4889–4897. https://doi.org/10.1210/jc.2010-0493
Iwamoto J (2014) Vitamin K2 therapy for postmenopausal osteoporosis. Nutrients 6:1971–1980. https://doi.org/10.3390/nu6051971
Iketani T, Kiriike N, Stein MB, Nagao K, Nagata T, Minamikawa N, Shidao A, Fukuhara H (2003) Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res 117:259–269. https://doi.org/10.1016/S0165-1781(03)00024-6
Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K, Nagata K, Kojima M (2004) Ghrelin directly regulates bone formation. J Bone Miner Res 20:790–798. https://doi.org/10.1359/JBMR.041237
Misra M, Miller KK, Stewart V, Hunter E, Kuo K, Herzog DB, Klibanski A (2005) Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90:5082–5087. https://doi.org/10.1210/jc.2005-0512
Fazeli PK, Lawson EA, Faje AT, Eddy KT, Lee H, Fiedorek FT, Breggia A, Gaal IM, DeSanti R, Klibanski A (2018) Treatment with a ghrelin agonist in outpatient women with anorexia nervosa. J Clin Psychiatry 79:17m11585. https://doi.org/10.4088/JCP.17m11585
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
All authors participated in the literature search, reading, and summarizing of the literature and developing the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Chermaine Hung, Marcus Muñoz, and Amal Shibli-Rahhal have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hung, C., Muñoz, M. & Shibli-Rahhal, A. Anorexia Nervosa and Osteoporosis. Calcif Tissue Int 110, 562–575 (2022). https://doi.org/10.1007/s00223-021-00826-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-021-00826-3